These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 29527628)

  • 41. The antinociceptive effect of systemic gabapentin is related to the type of sensitization-induced hyperalgesia.
    Curros-Criado MM; Herrero JF
    J Neuroinflammation; 2007 Jun; 4():15. PubMed ID: 17550605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emblica officinalis corrects functional, biochemical and molecular deficits in experimental diabetic neuropathy by targeting the oxido-nitrosative stress mediated inflammatory cascade.
    Tiwari V; Kuhad A; Chopra K
    Phytother Res; 2011 Oct; 25(10):1527-36. PubMed ID: 21394805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gabapentin-induced rhabdomyolysis in a patient with diabetic neuropathy.
    Bilgir O; Calan M; Bilgir F; Kebapçilar L; Yüksel A; Yildiz Y; Sari I
    Intern Med; 2009; 48(12):1085-7. PubMed ID: 19525604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence for the use of gabapentin in the treatment of diabetic peripheral neuropathy.
    Hemstreet B; Lapointe M
    Clin Ther; 2001 Apr; 23(4):520-31. PubMed ID: 11354388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient compliance with SSRIs and gabapentin in painful diabetic neuropathy.
    Giannopoulos S; Kosmidou M; Sarmas I; Markoula S; Pelidou SH; Lagos G; Kyritsis AP
    Clin J Pain; 2007; 23(3):267-9. PubMed ID: 17314587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ameliorative potential of rutin in combination with nimesulide in STZ model of diabetic neuropathy: targeting Nrf2/HO-1/NF-kB and COX signalling pathway.
    Mittal R; Kumar A; Singh DP; Bishnoi M; Nag TC
    Inflammopharmacology; 2018 Jun; 26(3):755-768. PubMed ID: 29094308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Symptomatic treatment of painful diabetic neuropathy].
    Maeda K; Yasuda H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():609-13. PubMed ID: 15999779
    [No Abstract]   [Full Text] [Related]  

  • 48. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3).
    Rao RD; Michalak JC; Sloan JA; Loprinzi CL; Soori GS; Nikcevich DA; Warner DO; Novotny P; Kutteh LA; Wong GY;
    Cancer; 2007 Nov; 110(9):2110-8. PubMed ID: 17853395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antihypernociceptive and neuroprotective effects of Combretin A and Combretin B on streptozotocin-induced diabetic neuropathy in mice.
    Mbiantcha M; Khalid R; Dawe A; Mehreen A; Atsamo DA; Ateufack G; Hamza D; Nana WY; Bomba FTD; Naeem RU; Izhar A
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):697-713. PubMed ID: 30759263
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic intrathecal infusion of gabapentin prevents nerve ligation-induced pain in rats.
    Chu LC; Tsaur ML; Lin CS; Hung YC; Wang TY; Chen CC; Cheng JK
    Br J Anaesth; 2011 May; 106(5):699-705. PubMed ID: 21441243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prophylactic L-arginine and ibuprofen delay the development of tactile allodynia and suppress spinal miR-155 in a rat model of diabetic neuropathy.
    El-Lithy GM; El-Bakly WM; Matboli M; Abd-Alkhalek HA; Masoud SI; Hamza M
    Transl Res; 2016 Nov; 177():85-97.e1. PubMed ID: 27392937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gabapentin treatment for notalgia paresthetica, a common isolated peripheral sensory neuropathy.
    Loosemore MP; Bordeaux JS; Bernhard JD
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1440-1. PubMed ID: 17958872
    [No Abstract]   [Full Text] [Related]  

  • 53. Effectiveness of oral clonidine and gabapentin on peripheral neuropathy in diabetic patients in southwestern Iran: a randomized clinical trial.
    Hassanzadeh S; Bagheri S; Majid Ahmadi S; Ahmadi SA; Moradishibany I; Dolatkhah H; Reisi S
    BMC Endocr Disord; 2023 Oct; 23(1):224. PubMed ID: 37845651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antinociceptive effect of the novel compound OT-7100 in a diabetic neuropathy model.
    Miki S; Yoshinaga N; Iwamoto T; Yasuda T; Sato S
    Eur J Pharmacol; 2001 Nov; 430(2-3):229-34. PubMed ID: 11711035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diabetic neuropathy: new strategies for treatment.
    Várkonyi T; Kempler P
    Diabetes Obes Metab; 2008 Feb; 10(2):99-108. PubMed ID: 17593238
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Photobiostimulation reverses allodynia and peripheral nerve damage in streptozotocin-induced type 1 diabetes.
    Rocha IRC; Ciena AP; Rosa AS; Martins DO; Chacur M
    Lasers Med Sci; 2017 Apr; 32(3):495-501. PubMed ID: 28138810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study.
    Pérez C; Navarro A; Saldaña MT; Masramón X; Rejas J
    Clin Ther; 2010 Jul; 32(7):1357-70. PubMed ID: 20678683
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FK1706, a novel non-immunosuppressive immunophilin ligand, modifies the course of painful diabetic neuropathy.
    Yamazaki S; Yamaji T; Murai N; Yamamoto H; Price RD; Matsuoka N; Mutoh S
    Neuropharmacology; 2008 Dec; 55(7):1226-30. PubMed ID: 18760290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.
    Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B
    Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel role for gabapentin in neuroprotection of central nervous system in streptozotocine-induced diabetic rats.
    Baydas G; Sonkaya E; Tuzcu M; Yasar A; Donder E
    Acta Pharmacol Sin; 2005 Apr; 26(4):417-22. PubMed ID: 15780189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.